EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.93M invested in Evoke Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$516K
2
+$503K
3
+$442K
4
NCM
Nantahala Capital Management
Connecticut
+$412K
5
Goldman Sachs
Goldman Sachs
New York
+$8.22K

Top Sellers

1
-$1.11K
2
-$236
3
-$7
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$516K
2
$503K
3
$442K
4
$412K
5
$18.2K
6
$16.5K
7
$8.22K
8
$6.63K
9
$4.52K
10
$893
11
$675
12
$229
13
$127
14
$40
15
–